NEW YORK (TheStreet) -- After the Monday holiday, U.S. equities are moving higher on Tuesday with the Nasdaq leading the way. TheStreet's Jonathan Marino takes a look at today's big headlines. 

U.S. stocks aren't the only indices enjoying gains on Tuesday. Both European and Asian markets are higher on news the Chinese central bank will infuse $42 billion worth of liquidity into its market as part of its stimulus program, he said. 

Turning to earnings, shares of Johnson & Johnson (JNJ) are lower despite beating on top- and bottom-line estimates. The company's slightly lower-than-expected full-year guidance is likely responsible for the decline. 

Delta Air Lines (DAL) is higher after beating estimates on revenue and earnings per share, while Verizon Communications (VZ) is lower after beating on its top- and bottom-line estimates. 

Advanced Micro Devices (AMD), Texas Instruments (TXN) and Xilinx (XLNX) will report earnings after the close, Marino said. 

Finally, Marino said that Jim Cramer, who co-manages the Actions Alerts PLUS portfolio, likes Nike (NKE), saying it looks good going forward. Shares are down 8% from its highs made on Dec. 9, but should be considered a buying opportunity, according to Cramer. 

The company, an AAP holding, should continue to benefit from strong sales in Western Europe, as well as solid marketing campaigns for the World Cup and the Olympics, Marino concluded.

-- Written by Bret Kenwell in Petoskey, Mich.

Bret Kenwell currently writes, blogs and also contributes to Robert Weinstein's Weekly Options Newsletter. Focuses on short-to-intermediate-term trading opportunities that can be exposed via options. He prefers to use debit trades on momentum setups and credit trades on support/resistance setups. He also focuses on building long-term wealth by searching for consistent, quality dividend paying companies and long-term growth companies. He considers himself the surfer, not the wave, in relation to the market and himself. He has no allegiance to either the bull side or the bear side.

If you liked this article you might like

Buy Stocks That Are Right for You: Cramer's 'Mad Money' Recap (Friday 2/16/18)

Buy Stocks That Are Right for You: Cramer's 'Mad Money' Recap (Friday 2/16/18)

Jim Cramer: These 4 Stocks Seem Attractive Right Here

Jim Cramer: These 4 Stocks Seem Attractive Right Here

Jim Cramer: Drug Stocks on the Move

Jim Cramer: Drug Stocks on the Move

The Decline In Johnson & Johnson Could Be Close to Being Over

The Decline In Johnson & Johnson Could Be Close to Being Over

Opioid Litigants Get Boost From Senate Report

Opioid Litigants Get Boost From Senate Report